The FDA tells Novo Nordisk (NOVOB DC) that its Wegovy AD is false or misleading
Importance
Level 1
#NETHERLANDS#EUROPE#NOVO NORDISK A/S#NOVOB.DC#FDA#EQUITIES#EU SESSION#US SESSION#FOOD RETAIL#CONSUMER STAPLES DISTRIBUTION & RETAIL#CONSUMER STAPLES DISTRIBUTION & RETAIL (GROUP)#KONINKLIJKE AHOLD DELHAIZE NV#AD#EURO STOXX 50#AEX 25 INDEX#EUROPEAN EQUITIES